HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
RCT
Relacorilant maintained hypertension control versus placebo in adults with endogenous hypercortisolism
New Drug Helps Control High Blood Pressure in Cushing's
This phase 3 randomised-withdrawal study enrolled 152 adults with endogenous hypercortisolism and hypertension or hyperglycaemia.
Imagine your body is stuck in a permanent "fight or flight" mode.
Apr 24, 2026
Diabetes & Endocrinology
Cohort
Biochemical remission of Cushing's syndrome reduces hepatic steatosis and fibrosis indices in adult patients
Cushing’s Syndrome Often Leads to Fatty Liver Disease
This retrospective cohort study evaluated 126 adult patients with endogenous Cushing's syndrome (CS).
New findings reveal fatty liver is common in Cushing’s syndrome, yet liver fat may improve after treatment ends, offering hope for patients.
Frontiers
Apr 24, 2026
Diabetes & Endocrinology
Cohort
High 1-mg DST, low PNI, diabetes, and poor bone health predict infection in Cushing syndrome surgery
High Cortisol Levels Signal Higher Infection Risk Before Surgery
This retrospective single-center cohort study evaluated 113 patients with confirmed Cushing syndrome.
Doctors can now spot patients at high risk for surgery infections days before the operation starts.
Frontiers
Apr 24, 2026
Diabetes & Endocrinology
Sys. Review
Review examines current endocrine causes of secondary osteoporosis and clinical management approaches
Why Normal Hormones Can Still Break Bones
This review synthesizes evidence on endocrine-related secondary osteoporosis across conditions like hypercortisolism and male hypogonadism.
You might think strong bones only come from aging women or older men.
Frontiers
Apr 21, 2026